Westside Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.69M | Buy |
2,245
+10
| +0.4% | +$10.2K | 0.35% | 70 |
|
|
2026
Q1 | $2.06M | Sell |
2,235
-55
| -2% | -$55.8K | 0.32% | 80 |
|
|
2025
Q4 | $2.46M | Sell |
2,290
-28
| -1% | -$26.8K | 0.39% | 64 |
|
|
2025
Q3 | $1.79M | Buy |
2,318
+198
| +9% | +$147K | 0.29% | 82 |
|
|
2025
Q2 | $1.65M | Buy |
2,120
+152
| +8% | +$118K | 0.31% | 85 |
|
|
2025
Q1 | $1.62M | Buy |
1,968
+5
| +0.3% | +$4.16K | 0.35% | 75 |
|
|
2024
Q4 | $1.52M | Sell |
1,963
-105
| -5% | -$86.9K | 0.32% | 80 |
|
|
2024
Q3 | $1.83M | Sell |
2,068
-200
| -9% | -$180K | 0.39% | 62 |
|
|
2024
Q2 | $2.05M | Sell |
2,268
-8
| -0.4% | -$6.4K | 0.47% | 52 |
|
|
2024
Q1 | $1.77M | Sell |
2,276
-2
| -0.1% | -$1.42K | 0.42% | 62 |
|
|
2023
Q4 | $1.33M | Sell |
2,278
-198
| -8% | -$116K | 0.34% | 72 |
|
|
2023
Q3 | $1.33M | Sell |
2,476
-162
| -6% | -$83.5K | 0.38% | 67 |
|
|
2023
Q2 | $1.24M | Hold |
2,638
| – | – | 0.35% | 76 |
|
|
2023
Q1 | $906K | Sell |
2,638
-90
| -3% | -$30.4K | 0.27% | 94 |
|
|
2022
Q4 | $998 | Sell |
2,728
-40
| -1% | -$14.2K | ﹤0.01% | 260 |
|
|
2022
Q3 | $895 | Buy |
2,768
+125
| +5% | +$39.6K | ﹤0.01% | 271 |
|
|
2022
Q2 | $856 | Hold |
2,643
| – | – | ﹤0.01% | 266 |
|
|
2022
Q1 | $756 | Buy |
2,643
+2,093
| +381% | +$539K | ﹤0.01% | 275 |
|
|
2021
Q4 | $151 | Hold |
550
| – | – | ﹤0.01% | 323 |
|
|
2021
Q3 | $127 | Hold |
550
| – | – | ﹤0.01% | 325 |
|
|
2021
Q2 | $126 | Hold |
550
| – | – | ﹤0.01% | 320 |
|
|
2021
Q1 | $102 | Buy |
550
+25
| +5% | +$4.89K | ﹤0.01% | 327 |
|
|
2020
Q4 | $88 | Sell |
525
-35
| -6% | -$5.23K | ﹤0.01% | 304 |
|
|
2020
Q3 | $82 | Hold |
560
| – | – | ﹤0.01% | 312 |
|
|
2020
Q2 | $91 | Sell |
560
-140
| -20% | -$21.5K | ﹤0.01% | 282 |
|
|
2020
Q1 | $97 | Buy |
+700
| New | +$96.2K | ﹤0.01% | 280 |
|
|
2019
Q2 | $77 | Buy |
+700
| New | +$82.4K | ﹤0.01% | 275 |
|
|
2018
Q4 | $81K | Sell |
700
-100
| -13% | -$11.2K | 0.03% | 233 |
|
|
2018
Q3 | $86.1K | Sell |
800
-294
| -27% | -$29.4K | 0.03% | 217 |
|
|
2018
Q2 | $93.9K | Hold |
1,094
| – | – | 0.03% | 235 |
|
|
2018
Q1 | $82.8K | Hold |
1,094
| – | – | 0.05% | 232 |
|
|
2017
Q4 | $94.2K | Hold |
1,094
| – | – | 0.05% | 225 |
|
|
2017
Q3 | $95.2K | Hold |
1,094
| – | – | 0.06% | 204 |
|
|
2017
Q2 | $90K | Buy |
1,094
+100
| +10% | +$8.16K | 0.06% | 207 |
|
|
2017
Q1 | $85.1K | Buy |
994
+175
| +21% | +$14K | 0.04% | 208 |
|
|
2016
Q4 | $61.6K | Buy |
+819
| New | +$61K | 0.04% | 174 |
|
Other funds holding LLY
SC
ONB
GIM
Westside Investment Management's LLY Position: Q2 2026 in Review
Westside Investment Management increased its Eli Lilly (LLY) stake by 0.45% in Q2 2026, buying an estimated $10.2K and bringing the position to 2,245 shares worth $2.69M. The position accounts for 0.35% of the portfolio, ranked #70.
Westside Investment Management first reported a position in LLY in Q4 2016 and has held it in 36 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Westside Investment Management held 2,245 shares of Eli Lilly worth $2.69M as of Q2 2026.
- Westside Investment Management bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 0.35% of Westside Investment Management's portfolio in Q2 2026, its #70 holding.
- Westside Investment Management first reported a position in Eli Lilly in Q4 2016 and has held it in 36 quarters since.
- 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.